{"cik":1834105,"taxonomy":"us-gaap","tag":"IncreaseDecreaseInAccountsReceivable","label":"Increase (Decrease) in Accounts Receivable","description":"The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.","entityName":"Impact     BioMedical, INC.","units":{"USD":[{"start":"2022-01-01","end":"2022-06-30","val":37000,"accn":"0001493152-23-036365","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-10-05"},{"start":"2023-01-01","end":"2023-06-30","val":94000,"accn":"0001493152-23-036365","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-10-05"},{"start":"2023-01-01","end":"2023-06-30","val":94000,"accn":"0001493152-24-031635","fy":2024,"fp":"Q2","form":"10-Q","filed":"2024-08-13"},{"start":"2024-01-01","end":"2024-09-30","val":-128000,"accn":"0001493152-24-044792","fy":2024,"fp":"Q3","form":"10-Q","filed":"2024-11-12"},{"start":"2024-01-01","end":"2024-09-30","val":-128000,"accn":"0001493152-25-021286","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-11-07"},{"start":"2024-01-01","end":"2024-12-31","val":-128000,"accn":"0001493152-26-009711","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-11","frame":"CY2024"},{"start":"2025-01-01","end":"2025-06-30","val":-4000,"accn":"0001641172-25-023809","fy":2025,"fp":"Q2","form":"10-Q","filed":"2025-08-14"},{"start":"2025-01-01","end":"2025-09-30","val":11000,"accn":"0001493152-25-021286","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-11-07"},{"start":"2025-01-01","end":"2025-12-31","val":1000,"accn":"0001493152-26-009711","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-11","frame":"CY2025"},{"start":"2026-01-01","end":"2026-03-31","val":-5000,"accn":"0001493152-26-022512","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-12","frame":"CY2026Q1"}]}}